AMCP to Supreme Court: Ruling Against PCMA Could Raise Health Costs
The Academy of Managed Care Pharmacy (AMCP) in an amicus brief filed in the Supreme Court tells the court ruling [...]
Oracle Founder Looks to Partner with White House to Combat Coronavirus
Oracle Founder Larry Ellison is working with the Trump White House in a bid to use big data in the [...]
Opinion Piece Spotlights NICE’s Drug Assessment Methodology in Post-Brexit Britain
Lexington Communications Senior Consultant Rebecca Lanning in a recent opinion piece published on Pharmafield looks at NICE's drug assessment protocol [...]
Regulating Drug Prices: What’s the Best System?
A recent Pharmafile article weighs the pros and cons of several large health care systems' approach to controlling the price [...]
NICE Publishes COVID-19 Guidelines
The National Institute for Health and Care Excellence (NICE) on March 21 published a new set of guidelines that address [...]
AMCP Hosting Webinar on Medicare Advantage, Part D Proposed Rule
The Academy of Managed Care Pharmacy (AMCP) is hosting a webinar today, March 23, on CMS' proposed Contract Year 2021 [...]
AMCP Seeks Comments for New FDA Biologics Guidance Documents
The Academy of Managed Care Pharmacy (AMCP) is asking members to submit their input on two new guidance documents released [...]
Pharma Responds to Canadian Pricing Regulations
Pharmaceutical companies are changing their business interests in Canada following new pricing regulations, according to a Pink Sheet report. According [...]
Kentucky Governor Bolsters Pharmacist Prescribing Rights Amid Outbreak
Kentucky Gov. Andy Beshear in a new executive order has given the state's pharmacists the ability to fill prescriptions for [...]
NICE Taps Leng as New Chief Executive
The U.K.'s National Institute for Health and Care Excellence (NICE) announced the appointment of Gillian Leng, NICE's current deputy chief [...]
Beijing Investigating Woman Who Entered Country with COVID-19 Symptoms
Beijing authorities have opened an investigation into a woman, surnamed Li, who reportedly entered China to attend a company meeting [...]
U.S. Looks to Limit Out-of-Pocket Costs for Insulin Under Medicare
The Trump administration announced a new plan to limit the out-of-pocket costs for insulin to $35 month for Medicare patients, [...]
Lessons From U.K.’s NICE
A recent opinion piece published on BMJ looks at some of the key lessons to be gleaned the U.K.'s National [...]
Azar: White House Doesn’t Believe in Price Controls as Researchers Work on Coronavirus Vaccine
Health and Human Services Secretary Alex Azar during recent testimony before Congress regarding the Coronavirus said the Trump administration doesn't [...]
Report: Extended-release Drugs Could be Costing Billions
A recent study published in JAMA Network Open suggests the U.S. health care system could save billions if doctors prescribed [...]
Analysis Looks at ICER’s FDA Outreach Plan
A recent analysis by the Pink Sheet spotlights a new initiative by the Institute for Clinical and Economic Review (ICER) [...]
CMS Testing Waters with Risk-Sharing Deals with ACO Program
The Centers for Medicare and Medicaid Services (CMS) is testing risk-sharing agreements in Medicare's Direct Contracting program, according to a [...]
Impact of Drug Pricing Controls on Innovation
The pharmaceutical industry, citing concerns over innovation, has consistently pushed back against the U.S. government's efforts to tame drug prices. [...]
Article Reflects on NICE’s Achievements, Economic Evaluation Methods
University of York's Mark Sculpher and Stephen Palmer in a recent article published in PharmacoEconomics discuss the National Institute for [...]
Wynne Health Group’s LaRosa Talks Drug Pricing Intiatives
Josh LaRosa, policy director at Wynne Health Group, in a new Relentless Health Value podcast highlights a number of drug [...]
Report Outlines How States Can Act on Drug Spending
A recent report by the Center for American Progress outlines how states can take action to reduce prescription drug spending. [...]
Massachusetts to Pay for Zolgensma on One Condition: It Must Work
Massachusetts' Medicaid program, MassHealth, has inked a conditional deal for Novartis' $2 million one-time spinal muscular atrophy (SMA) gene therapy, [...]
Rosenthal Blasts Health System, Policymakers on Surprise Bills
Journalist and physician Elisabeth Rosenthal in a recent opinion piece published on the New York Times criticizes the health care [...]
Price of Decades-Old Drug Skyrockets, Georgia City Sues
The price of Belcher Pharmaceuticals' Acthar gel skyrocketed after having been granted orphan status by the Food and Drug Administration, [...]
Utah Flies Public Workers to Mexico for Cheaper Drugs
Utah is taking drastic steps to cut down on health costs by flying public workers to Mexico for cheaper prescription [...]